Host factors may influence Covid-19 severity more than viral genetic variation

Last Updated on

May 22, 2020 – Host factors (i.e., disease phenotypes and/or predispositions) instead of viral genetic variation seem to impact more on sickness severity among Covid-19 patients, as indicated by an investigation from China. Scientists in Shanghai analyzed clinical, atomic, and immunological information from in excess of 300 individuals with affirmed Covid-19. While contamination with SARS-CoV-2 can prompt serious respiratory ailment and passing, it likewise can bring about progressively mellow pneumonia in certain patients. 

As they just reported in the Journal Nature, researchers at Fudan University revealed two diverse SARS-CoV-2 strains inside their patient companion, yet found these hereditary viral varieties didn’t essentially influence quiet results. Rather, having low degrees of lymphocytes seemed to anticipate sickness seriousness. “The determinants of sickness seriousness appeared to stem for the most part from patient factors, for example, age, lymphocytopenia, and its related cytokine storm, though popular hereditary variety didn’t altogether influence the results,” the lead author Dr. Lu and his partners wrote in their paper. 

The specialists examined information gathered from 326 people. Of these, five were asymptomatic and had no fever, respiratory manifestations, or radiological proof of sickness, however they had affirmed SARS-CoV-2 diseases. In contrast, 293 people had mellow malady, characterized as having a fever and radiological proof of pneumonia. Twelve patients had serious ailment with brevity of breath and ground-glass murkiness in their lungs, and 16 patients had basic infection, created intense respiratory misery condition, and required a ventilator or extracorporeal layer oxygenation. As of the start of April 2020, most of these patients had been released; six patients, however, had died. 

Viral sequencing information was accessible for 112 examples. When the specialists looked at their viral genome information from their patients in Shanghai in comparison to the first announced SARS-CoV-2 infection samples from Wuhan, they could distinguish 66 equivalent and 103 non-interchangeable variations in nine protein-coding loci. 

Utilizing the viral genomes from 94 cases and 221 different SARS-CoV-2 arrangements in the GISAID database, the scientists led a phylogenetic examination of their samples. They isolated into two significant clades and demonstrated the most punctual zoonotic overflow occasion may have happened in late November 2019, which the analysts noted was in accordance with others’ discoveries.

In any case, infections from the two clades prompted comparable sickness among patients. The scientists revealed no factual contrasts in ailment seriousness, lymphocyte check, CD3+ T-cell count, C-responsive protein, D-dimer, or viral shedding span. Rather, patient factors seemed to influence malady seriousness. Specifically, leukocytopenia was progressively normal among extreme and fundamentally sick patients, which the specialists said affirmed earlier reports. CD3+ T-cells were most seriously influenced and were smothered in extreme and basic patients. They likewise noticed that CD4+ and CD8+ cell counts were diminished in these patients. 

Also, patients with basic and extreme Covid-19 had elevated levels of the cytokines IL-6 and IL-8 upon affirmation and treatment. These levels related with diminished lymphocyte count and proposed a connection between fiery cytokines (i.e., such as in a cytokine storm) and Covid-19 seriousness. 

By intently observing the atomic and immunological information in 326 instances of Covid-19 patients, the authors conclude that antagonistic results are related with exhaustion of CD3+ T lymphocytes which in turn is strongly connected to eruptions of cytokines, for example, IL-6 and IL-8. Age, the nearness of previous conditions, and sex likewise impacted illness seriousness, they noted.

See here a short sequence on the complicated life of a cytokine storm:

[printfriendl]

Tags: , , , , , , , , , , , , , , , ,
About the Author
Joseph Gut - thasso Ph.D.; Professor in Pharmacology and Toxicology. Senior expert in theragenomic and personalized medicine and individualized drug safety. Senior expert in pharmaco- and toxicogenetics. Senior expert in human safety of drugs, chemicals, environmental pollutants, and dietary ingredients.

Your opinion

Comment

No comments yet

thasso: conditions

thasso: newest tweets

thasso: recent comments

View my Flipboard Magazine.

thasso: categories

thasso: archives

thasso: simple chat

You must be a registered user to participate in this chat.

  • Newly discovered mutation could point to heart disease therapeutic target August 7, 2020
    New work led by Carnegie's Meredith Wilson and Steve Farber identifies a potential therapeutic target for clogged arteries and other health risks that stem from an excess of harmful fats in the bloodstream. Their findings are published by PLOS Genetics.
  • Genetic cause of congenital malformation discovered August 7, 2020
    Spontaneous mutations of a single gene are likely to cause serious developmental disorders of the excretory organs and genitalia. This is shown in an international study led by the University of Bonn and published in the journal Frontiers in Cell and Developmental Biology. The researchers also owe their findings to an unusual model organism: the […]
  • Novel approach reduces SCA1 symptoms in animal model August 7, 2020
    Research has shown that a mutation in the ATAXIN-1 gene leads to accumulation of Ataxin-1 (ATXN1) protein in brain cells and is the root cause of a rare genetic neurodegenerative disease known as spinocerebellar ataxia type 1 (SCA1). How healthy cells maintain a precise level of ATXN1 has remained a mystery, but now a study […]
  • Alport Syndrome: Research highlights link between genotype and treatment effectiveness August 7, 2020
    A large-scale analysis of the clinical characteristics of Alport syndrome in Japanese patients has revealed that the effectiveness of existing treatment with ACE inhibitors and/or angiotensin receptor blockers (RAS inhibitors) varies depending on the type of mutation in the syndrome's causal gene (COL4A5). RAS inhibitors are widely administered to patients with chronic kidney diseases as […]
  • Tasmanian devil research offers new insights for tackling cancer in humans August 6, 2020
    A rare, transmissible tumor has brought the iconic Tasmanian devil to the brink of extinction, but new research by scientists at Washington State University and the Fred Hutchinson Cancer Research Center in Seattle indicates hope for the animals' survival and possibly new treatment for human cancers.
  • checkmate 743 shows that dual immunotherapy, nivolumab + ipilimumab August 8, 2020
    The combination of first-line nivolumab and ipilimumab demonstrated an improvement of overall survival for patients with unresectable malignant pleural mesothelioma compared to platinum-based chemotherapy, according to research presented today at the International Association for the Study of Lung Cancer Virtual Presidential Symposium.
  • Phase 3 eXalt3 study shows significantly longer progression-free survival August 8, 2020
    Patients with non-small cell lung cancer (NSCLC) carrying anaplastic lymphoma kinase (ALK) gene alterations who received ensartinib experienced substantially longer progression-free survival than a matched group of patients who received crizotinib.
  • Addition of sintilimab to pemetrexed and platinum improved progression-free survival August 8, 2020
    The interim analysis of ORIENT-11, a phase III double-blind randomized trial has shown a nearly two-fold increase in progression-free survival with addition of sintilimab to chemotherapy in patients with advanced or metastatic non-squamous non-small cell lung cancer without EGFR or ALK genomic aberrations, according to research data presented today at the International Association for the […]
  • Heart attack case rates, treatment approaches, outcomes during COVID-19 pandemic August 7, 2020
    The increases and decreases in patient volume and associated changes in treatment experienced by individuals presenting with acute heart attack (myocardial infarction) before and immediately after the onset of the COVID-19 pandemic are examined in this observational study.
  • COVID recovery choices shape future climate August 7, 2020
    A new international study, led by the University of Leeds, warns that even with some lockdown measures staying in place to the end of 2021, without more structural interventions global temperatures will only be roughly 0.01°C lower than expected by 2030. However, the study estimates that including climate policy measures as part of an economic […]
Top